文档下载 文档下载导航
设为首页 | 加入收藏
搜索 请输入内容:  
 导航当前位置: 文档下载 > 所有分类 > 医药卫生 > 捷克 黑色素瘤
侵权投诉

捷克 黑色素瘤

小蘖碱

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2005, 149(2):461–3.© S. Leta iová, S. Jantová, M. Mú ková, M. Theiszová

461

ANTIPROLIFERATIVE ACTIVITY OF BERBERINE IN VITRO AND IN VIVO

Silvia Leta iováa, Soňa Jantováa, Marta Mú kováb, Marica Theiszováa

Department of Biochemistry and Microbiology, Faculty of Chemical and Food Technology, Slovak University of Technology, Radlinského 9, SK-81237 Bratislava, Slovak Republicb

Drug Research Institute, Horná 36, SK-90001 Modra, Slovak Republice-mail: silvia.letasiova@stuba.sk

a

Received: June 10, 2005; Accepted: September 25, 2005

Key words: Berberine/B16 cells/C57BL/6 mice/Antiproliferative activity

Berberine, an isoquinoline plant alkaloid acted cytotoxically in vitro on tumour cell lines B16. Its anticancer activ-ity in vivo was studied with the transplanted B16 line in the range of doses from 1 mg/kg to 10 mg/kg. The signi cant reduction of tumor volume was observed on day 16 at doses of 5 and 10 mg/kg. The dose of 1 mg/kg stimulated the tumor mass, but other tested concentration, 5 and 10 mg/kg, reduced the tumor weight.

INTRODUCTION

Berberine (2,3-methylenedioxy-9,10-dimethoxyprotoberber-ine chloride) is an isoquinoline alkaloid, which has a wide range of pharmacological and biochemical e ects. It has demonstrated signi cant antimicrobial activity against a variety of organisms including bacteria, fungi, protozoans, viruses, chlamydia, and helminths. It can also be used as an antidiarrhea, antihypertension, antiarrhythmias and an-tii amantory agent. Berberine is demonstrated to possess antitumor activity1. The cell cycle analysis showed the ac-cumulation of cells in the G0/G1 phase and relative decrease of the S phase. Chung et al.2 reported that berberine induces inhibition of the N-acetyltransferase activity and 2-amino uo-rene-DNA adduct formation in human leukemia cell in a dose-dependent manner. It has been shown that berberine induces apoptosis in the murine thymocytes and in the pro-myelocytic leukemic HL-60 cells. Dose-dependent e ects of berberine on the cell cycle and apoptosis in the Balb/c 3T3 cells were also reported. The e ect of berberine was demon-strated by ow cytometric analysis in the human hepatoma HepG2 cells. It has been shown that the S phase fraction is signi cantly reduced.

In the previous experiments the e ect of berberine on the proliferation, cell cycle pro le and apoptosis in the human tumor HeLa and murine leukemia L1210 cell lines was investigated. It has been shown that berberine induces apoptosis in L1210 cells3. In this study, the antiprolifera-tive activity in vitro on murine melanoma B16 cells and in vivo on male C57BL/6 mice was studied.MATERIAL AND METHODS

Murine melanoma cell line B16 (obtained from American Type Culture Collection, Rockville, MD, USA) grown in supplemented RPMI 1640 medium (Biocom

Bratislava) at 37 C in a humidi ed atmosphere contain-ing 5 % CO2 was used. Cell viability was assessed by 0.4 % trypan blue staining. To study the antiproliferative activity in vivo, 5–6-week-old male C57BL/6 mice obtained from Velaz (Czech Republic) were used. Berberine obtained from Sigma Chemicals (St Louis, MD) was dissolved in dimethyl sulfoxide (DMSO). All other chemicals were obtained from Sigma Chemicals (St Louis, MD).

Antiproliferative activity in vitro was measured by the cell growth inhibition assay. The starting inoculum of 1.34 × 105 B16 cells/ml was used. After 24 h of incubation, ber-berine (concentrations of 0.001, 0.01, 0.1, 1, 5, 10, 25, 50, 75 and 100 µg/ml) was added to the cells. Control cells were treated with DMSO, its nal concentration never ex-ceeded 1%. After 24, 48 and 72 h of berberine treatment, B16 cells were harvested in triplicate, rst washed with PBS, then harvested by 0.25% trypsin, and latter resus-pended. Cell growth and viability were assessed by direct counting of 0.4% trypan blue dye–excluding cells.

When studying the antiproliferative activity in vivo, cell suspensions of B16 cells (5 × 104 / 0.1 ml PBS / mouse) were injected into gastrocnemius muscle of mice. The day of cell implantation was designed as day 0. Tested compound, berberine, and vehicle, respectively were ad-ministered intraperitoneally every day within 15 days from the day of cancer cell injection. As a vehicle carboxymeth-ylcellulose was used. The group treated with carboxymeth-ylcellulose was designed as the control. Berberine was used at concentrations of 1,5 and 10 mg/kg. Doses were selected on the basis of the toxicity test. The weight of the animals was monitored twice per week. The physical activity of the mice was observed daily. Tumor growth was measured twice per week and tumor volume was esti-mated by the formula length × width2/2. At the end of the experiment, on day 16, the animals were sacri ced with cervical dislocation. The tumors were separated from the surrounding muscles and dermis, excised and weighed.

第1页

你可能喜欢

热门文档

相关文档

  • 黑色素瘤

    黑色素瘤介绍 主要内容 1 2 3 4 黑色素瘤形成与发病机制 黑色素瘤临床表现 治疗与预后 黑色素瘤(melanoma) 黑色素瘤是一种能产生黑色素的高度恶性肿瘤,又称...

  • 黑色素瘤解析

    黑人少见。编辑本段分类 构成所有的恶性黑色素瘤只有一种恶性细胞类型,即被称作黑色素细胞的恶性色素产生细胞,但它们通过其形态,如梭形、圆柱形,而存在一些很少的...

  • 中国黑色素瘤诊治指南(2011版)

    19 ? 5 中 国黑 色素瘤诊治指南(0 )21 1版 CC黑 色素 瘤专 家委 员会 SO 【 关键词 】 恶性黑色素瘤 ;中国; 诊断; 治疗 ; 指南 中图分类号:795...

  • 恶性黑色素瘤

    部分恶黑呈现皮肤色,又叫作 无色素的恶性黑素瘤。 欧美高加索白种人最常见的是浅表扩散型恶性黑素瘤, 主要分布于躯干和四肢, 从病理上看 主要是以水平侵袭为主...

  • 黑色素瘤的预防方法有哪些

    http://www.qiuyi.cn/ 黑色素瘤的预防方法有哪些黑色素瘤 60%是由黑痣恶变的,因此如果发现身体各个部位的小黑痣出现增大、颜色 加深, 边缘不规则,甚至发痒、破...

  • 恶性黑色素瘤

    恶性黑色素瘤_临床医学_医药卫生_专业资料。恶性黑色素瘤 (malignant melanoma,MM) 目录一、 二、 三、 四、 五、 六、 七、 八、 九、 概述 流行病学与...

  • 赴美就医-黑色素瘤患者的福音

    赴美就医-黑色素瘤患者的福音_临床医学_医药卫生_专业资料。我现在已经开始了我的新生活。毕竟,我经历过了癌症 - 我自己的癌还有简的- 我把自己训练成为一名...

  • 黑色素瘤

    黑色素瘤_临床医学_医药卫生_专业资料。恶性黑色素瘤是一种产生黑色素的高度恶性肿瘤,仅少数为无色素恶性黑色素瘤。发病率为全部恶性肿瘤的1%-3%,近年有上升...

  • NRAS突变的黑色素瘤分子机制研究进展

    NRAS突变的黑色素瘤分子机制研究进展_医药卫生_专业资料。NRAS 突变的黑色素瘤分子机制研究进展 【摘要】NRAS 突变的黑色素瘤中有一些经典的信号通路,与肿瘤的...

站点地图 | 文档上传 | 侵权投诉 | 手机版
本站所有资源均来自互联网,本站只负责收集和整理,均不承担任何法律责任,如有侵权等其它行为请联系我们.
文档下载 Copyright 2013 doc.guandang.net All Rights Reserved.  -  email